Table 2.

Unadjusted outcomes of patients with streptococcal toxic shock syndrome.

Outcome	Overall*	No IVIG	IVIG	P**
Overall length of stay (days)	10 (5 - 16)	7 (5 - 14)	14 (8 - 23)	<0.001
ICU length of stay (days)***	4 (2 - 9)	3 (2 - 5)	6 (3 - 11)	<0.001
Total cost ($)	24,206 (12,448 – 60,865)	15,520 (8,706 – 34,824)	43,546 (24,358 – 93,466)	<0.001
Drug cost ($)	6,315 (2,383 – 14,002)	2,665 (1,520 – 6,553)	13,060 (7,202 – 21,972)	<0.001
Supply cost ($)	739 (179 – 2,603)	521 (116 – 1,577)	1,486 (413 – 4,208)	<0.001
Laboratory cost ($)	3,784 (1,483 – 10,778)	2,464 (1,186 - 4963)	7,002 (3,004 – 16,728)	<0.001
Clinical cost ($)	1,352 (259 – 5,515)	743 (212 – 3,183)	3,179 (655 – 7,396)	<0.001
Other cost ($)	9,006 (5,039 – 19,216)	6,406 (3,859 – 13,274)	13,638 (7,992 – 31,246)	<0.001

Abbreviations: ICU, intensive care unit; IVIG, intravenous immune globulin

^*Values are listed as median (interquartile range).

^**P<0.05 considered statistically significant

^***Only patients requiring intensive care until hospitalization were included.